AD mice with genetic TTR reduction (AD/TTR+/−) show increased Aβ levels and deposition compared to AD/TTR+/+ [13], whereas overexpressing human WT TTR in an AD mouse model decreases neuropathology and Aβ deposition [14]. Here, TTR is linked to Alzheimer disease.